BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 10557073)

  • 21. TC21 causes transformation by Raf-independent signaling pathways.
    Graham SM; Vojtek AB; Huff SY; Cox AD; Clark GJ; Cooper JA; Der CJ
    Mol Cell Biol; 1996 Nov; 16(11):6132-40. PubMed ID: 8887643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
    Kimmelman AC; Osada M; Chan AM
    Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EPS8 and E3B1 transduce signals from Ras to Rac.
    Scita G; Nordstrom J; Carbone R; Tenca P; Giardina G; Gutkind S; Bjarnegård M; Betsholtz C; Di Fiore PP
    Nature; 1999 Sep; 401(6750):290-3. PubMed ID: 10499589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
    Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
    Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells.
    Rosário M; Paterson HF; Marshall CJ
    EMBO J; 1999 Mar; 18(5):1270-9. PubMed ID: 10064593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
    Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of Rho in cell transformation by oncogenic Ras.
    Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
    Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of R-Ras signalling pathways.
    Self AJ; Caron E; Paterson HF; Hall A
    J Cell Sci; 2001 Apr; 114(Pt 7):1357-66. PubMed ID: 11257001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1.
    Recio JA; Páez JG; Maskeri B; Loveland M; Velasco JA; Notario V
    Cancer Res; 2000 Mar; 60(6):1720-8. PubMed ID: 10749145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1.
    Zhang Y; Saez R; Leal MA; Chan AM
    Oncogene; 1996 Jun; 12(11):2377-83. PubMed ID: 8649778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.
    Murphy GA; Graham SM; Morita S; Reks SE; Rogers-Graham K; Vojtek A; Kelley GG; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9966-75. PubMed ID: 11788587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
    Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
    Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase.
    Park SJ; Kim YY; Lim JY; Seo GJ; Kim J; Park SI; Park BJ
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1140-7. PubMed ID: 11587542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor.
    López-Barahona M; Bustelo XR; Barbacid M
    Oncogene; 1996 Feb; 12(3):463-70. PubMed ID: 8637701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
    Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.